Global Alzheimers Disease Diagnostics Market: Trends & Forecast to 2035
Report Enquiry
Global Alzheimers Disease Diagnostics Market By Diagnostic Type (Genetic Testing, Positron Emission Tomography, Electroencephalography, Magnetic Resonance Imaging, Computed Tomography, Neurological Exam, Mini-mental State Exam (MMSE), Biomarker Tests, Others), By End User (Academic Research Center, Hospitals, Diagnostic Centers, Pharmaceutical Companies, Clinics) And By Geography – Market Size, Opportunities, Trends And Forecast From 2023 to 2035
Report Code: EBI2000153 |
Report Published Date: December 2025
Global Alzheimers Disease Diagnostics Market: Trends & Forecast to 2035
Related Reports
Global Alzheimers Disease Diagnostics Market: Trends & Forecast to 2035
Global Computed Tomography Market: Trends & Forecast to 2035
Global Drug Delivery Devices Market: Trends & Forecast to 2035
Global Connected Medical Device Market: Trends & Forecast to 2035
Global Medical Waste Management Market: Trends & Forecast to 2035 |
The Global Alzheimer’s Disease Diagnostics Market was valued at approximately USD 7.84 Billion in 2024, reflecting the growing global burden of Alzheimer’s disease and other neurodegenerative disorders. Increasing awareness of early diagnosis, expanding aging populations, and rising healthcare expenditure across developed and emerging economies are key factors supporting the market’s robust size. The demand for accurate, early-stage Alzheimer’s diagnostic solutions continues to rise across hospitals, diagnostic centers, and research institutions.
The market is projected to reach USD 19.87 Billion by 2035, growing at a strong CAGR of 8.26% during 2025–2035. This accelerated growth is driven by the increasing prevalence of Alzheimer’s disease, technological advancements in biomarker-based diagnostics, and rising adoption of advanced brain imaging and genetic testing technologies. The shift toward early and pre-symptomatic diagnosis significantly strengthens long-term market expansion.
Market Challenges & Restraints
- High cost of advanced diagnostic procedures such as PET imaging and biomarker-based tests
- Limited accessibility to specialized diagnostic infrastructure in low- and middle-income regions
- Lack of standardized diagnostic protocols across healthcare systems
Regional Analysis: Leading and Fastest-Growing Alzheimers Disease Diagnostics Markets
North America Leads the Global Alzheimer’s Disease Diagnostics Market
North America emerged as the largest regional market. The region’s dominance is supported by:
- High Alzheimer’s disease prevalence
- Advanced healthcare infrastructure
- Strong reimbursement frameworks
- Early adoption of innovative diagnostic technologies
The US represents the largest contributor within North America, driven by extensive clinical research, favorable regulatory support, and rising demand for PET imaging, CSF biomarkers, and blood-based diagnostic tests.
Europe Holds a Strong Position Driven by Aging Demographics
Europe represents the second-largest regional market, supported by rapidly aging populations in countries such as Germany, France, Italy, and the UK. Increasing government initiatives for dementia screening, coupled with expanding use of neuroimaging and cognitive assessment tools, continues to boost the Alzheimer’s disease diagnostics market in the region. Europe’s focus on early intervention programs significantly enhances diagnostic adoption rates.
Asia Pacific Identified as a High-Growth Region
The Asia Pacific Alzheimer’s Disease Diagnostics Market is witnessing rapid growth, driven by rising awareness, improving healthcare access, and increasing elderly populations in China, Japan, India, and South Korea. Growing investments in diagnostic infrastructure, along with expanding clinical research activities, position Asia Pacific as a high-potential growth region during the forecast period.
Product Category Analysis & High-Growth Segments in the Alzheimers Disease Diagnostics Market
Genetic Testing Emerges as a Fast-Growing Diagnostic Segment
Genetic Testing is experiencing rapid growth due to increasing focus on risk assessment and early-stage detection, especially among high-risk populations. Growing awareness of APOE gene testing and advancements in molecular diagnostics are accelerating adoption, making genetic testing one of the most promising segments within the Alzheimer’s Disease Diagnostics Market.
Diagnostic Centers Gain Momentum with Specialized Services
Diagnostic Centers are gaining traction due to their specialized focus, faster turnaround times, and increasing accessibility. Rising outsourcing of imaging and laboratory diagnostics from hospitals is supporting growth in this segment, particularly in urban and semi-urban areas.
Trending Developments in the Global Alzheimers Disease Diagnostics Market
- Shift Toward Biomarker-Based Diagnostics: Blood-based and CSF biomarkers are gaining attention for early and minimally invasive diagnosis.
- Technological Advancements in Imaging: AI-enabled neuroimaging tools are improving diagnostic accuracy and speed.
- Growing Emphasis on Early Detection: Healthcare systems are prioritizing early-stage diagnosis to enable timely intervention and disease management.
Recent Market Developments & Innovation Landscape
The market is witnessing strong R&D activity focused on next-generation diagnostics, including AI-driven imaging analytics, digital cognitive assessment platforms, and precision diagnostics. Strategic collaborations between diagnostic companies, pharmaceutical firms, and research institutes are accelerating innovation and commercialization of novel Alzheimer’s diagnostic tools.
Key players operating in the global Alzheimers Disease Diagnostics market include:
- Roche Diagnostics
- Siemens Healthineers
- GE HealthCare
- Abbott Laboratories
- Thermo Fisher Scientific
- Fujirebio
- Biogen
- Eli Lilly and Company
- Quanterix Corporation
- Eisai Co., Ltd
Global Alzheimers Disease Diagnostics Market, By Region, 2023 - 2035 ($ Million)
|
Global Alzheimers Disease Diagnostics Market, By Diagnostic Test, 2023 - 2035 ($ Million)
|
|
Global Alzheimers Disease Diagnostics Market, By End User, 2023 - 2035 ($ Million)
|
|
North America Alzheimers Disease Diagnostics Market, By Country, 2023 - 2035 ($ Million)
|
|
North America Alzheimers Disease Diagnostics Market, By Diagnostic Test, 2023 - 2035 ($ Million)
|
|
North America Alzheimers Disease Diagnostics Market, By End User, 2023 - 2035 ($ Million)
|
|
US Alzheimers Disease Diagnostics Market, By Diagnostic Test, 2023 - 2035 ($ Million)
|
|
US Alzheimers Disease Diagnostics Market, By End User, 2023 - 2035 ($ Million)
|
|
Canada Alzheimers Disease Diagnostics Market, By Diagnostic Test, 2023 - 2035 ($ Million)
|
|
Canada Alzheimers Disease Diagnostics Market, By End User, 2023 - 2035 ($ Million)
|
|
Mexico Alzheimers Disease Diagnostics Market, By Diagnostic Test, 2023 - 2035 ($ Million)
|
|
Mexico Alzheimers Disease Diagnostics Market, By End User, 2023 - 2035 ($ Million)
|
|
Europe Alzheimers Disease Diagnostics Market, By Country, 2023 - 2035 ($ Million)
|
|
Europe Alzheimers Disease Diagnostics Market, By Diagnostic Test, 2023 - 2035 ($ Million)
|
|
Europe Alzheimers Disease Diagnostics Market, By End User, 2023 - 2035 ($ Million)
|
|
UK Alzheimers Disease Diagnostics Market, By Diagnostic Test, 2023 - 2035 ($ Million)
|
|
UK Alzheimers Disease Diagnostics Market, By End User, 2023 - 2035 ($ Million)
|
|
Germany Alzheimers Disease Diagnostics Market, By Diagnostic Test, 2023 - 2035 ($ Million)
|
|
Germany Alzheimers Disease Diagnostics Market, By End User, 2023 - 2035 ($ Million)
|
|
France Alzheimers Disease Diagnostics Market, By Diagnostic Test, 2023 - 2035 ($ Million)
|
|
France Alzheimers Disease Diagnostics Market, By End User, 2023 - 2035 ($ Million)
|
|
Italy Alzheimers Disease Diagnostics Market, By Diagnostic Test, 2023 - 2035 ($ Million)
|
|
Italy Alzheimers Disease Diagnostics Market, By End User, 2023 - 2035 ($ Million)
|
|
Spain Alzheimers Disease Diagnostics Market, By Diagnostic Test, 2023 - 2035 ($ Million)
|
|
Spain Alzheimers Disease Diagnostics Market, By End User, 2023 - 2035 ($ Million)
|
|
BeNeLux Alzheimers Disease Diagnostics Market, By Diagnostic Test, 2023 - 2035 ($ Million)
|
|
BeNeLux Alzheimers Disease Diagnostics Market, By End User, 2023 - 2035 ($ Million)
|
|
Russia Alzheimers Disease Diagnostics Market, By Diagnostic Test, 2023 - 2035 ($ Million)
|
|
Russia Alzheimers Disease Diagnostics Market, By End User, 2023 - 2035 ($ Million)
|
|
Nordic Region Alzheimers Disease Diagnostics Market, By Diagnostic Test, 2023 - 2035 ($ Million)
|
|
Nordic Region Alzheimers Disease Diagnostics Market, By End User, 2023 - 2035 ($ Million)
|
|
Rest of Europe Alzheimers Disease Diagnostics Market, By Diagnostic Test, 2023 - 2035 ($ Million)
|
|
Rest of Europe Alzheimers Disease Diagnostics Market, By End User, 2023 - 2035 ($ Million)
|
|
Asia Pacific Alzheimers Disease Diagnostics Market, By Country, 2023 - 2035 ($ Million)
|
|
Asia Pacific Alzheimers Disease Diagnostics Market, By Diagnostic Test, 2023 - 2035 ($ Million)
|
|
Asia Pacific Alzheimers Disease Diagnostics Market, By End User, 2023 - 2035 ($ Million)
|
|
China Alzheimers Disease Diagnostics Market, By Diagnostic Test, 2023 - 2035 ($ Million)
|
|
China Alzheimers Disease Diagnostics Market, By End User, 2023 - 2035 ($ Million)
|
|
India Alzheimers Disease Diagnostics Market, By Diagnostic Test, 2023 - 2035 ($ Million)
|
|
India Alzheimers Disease Diagnostics Market, By End User, 2023 - 2035 ($ Million)
|
|
Japan Alzheimers Disease Diagnostics Market, By Diagnostic Test, 2023 - 2035 ($ Million)
|
|
Japan Alzheimers Disease Diagnostics Market, By End User, 2023 - 2035 ($ Million)
|
|
South Korea Alzheimers Disease Diagnostics Market, By Diagnostic Test, 2023 - 2035 ($ Million)
|
|
South Korea Alzheimers Disease Diagnostics Market, By End User, 2023 - 2035 ($ Million)
|
|
Thailand Alzheimers Disease Diagnostics Market, By Diagnostic Test, 2023 - 2035 ($ Million)
|
|
Thailand Alzheimers Disease Diagnostics Market, By End User, 2023 - 2035 ($ Million)
|
|
Australia Alzheimers Disease Diagnostics Market, By Diagnostic Test, 2023 - 2035 ($ Million)
|
|
Australia Alzheimers Disease Diagnostics Market, By End User, 2023 - 2035 ($ Million)
|
|
Philippines Alzheimers Disease Diagnostics Market, By Diagnostic Test, 2023 - 2035 ($ Million)
|
|
Philippines Alzheimers Disease Diagnostics Market, By End User, 2023 - 2035 ($ Million)
|
|
Rest of Asia Pacific Alzheimers Disease Diagnostics Market, By Diagnostic Test, 2023 - 2035 ($ Million)
|
|
Rest of Asia Pacific Alzheimers Disease Diagnostics Market, By End User, 2023 - 2035 ($ Million)
|
|
South America Alzheimers Disease Diagnostics Market, By Country, 2023 - 2035 ($ Million)
|
|
South America Alzheimers Disease Diagnostics Market, By Diagnostic Test, 2023 - 2035 ($ Million)
|
|
South America Alzheimers Disease Diagnostics Market, By End User, 2023 - 2035 ($ Million)
|
|
Brazil Alzheimers Disease Diagnostics Market, By Diagnostic Test, 2023 - 2035 ($ Million)
|
|
Brazil Alzheimers Disease Diagnostics Market, By End User, 2023 - 2035 ($ Million)
|
|
Argentina Alzheimers Disease Diagnostics Market, By Diagnostic Test, 2023 - 2035 ($ Million)
|
|
Argentina Alzheimers Disease Diagnostics Market, By End User, 2023 - 2035 ($ Million)
|
|
Rest of South America Alzheimers Disease Diagnostics Market, By Diagnostic Test, 2023 - 2035 ($ Million)
|
|
Rest of South America Alzheimers Disease Diagnostics Market, By End User, 2023 - 2035 ($ Million)
|
|
Middle East & Africa Alzheimers Disease Diagnostics Market, By Country, 2023 - 2035 ($ Million)
|
|
Middle East & Africa Alzheimers Disease Diagnostics Market, By Diagnostic Test, 2023 - 2035 ($ Million)
|
|
Middle East & Africa Alzheimers Disease Diagnostics Market, By End User, 2023 - 2035 ($ Million)
|
|
Saudi Arabia Alzheimers Disease Diagnostics Market, By Diagnostic Test, 2023 - 2035 ($ Million)
|
|
Saudi Arabia Alzheimers Disease Diagnostics Market, By End User, 2023 - 2035 ($ Million)
|
|
UAE Alzheimers Disease Diagnostics Market, By Diagnostic Test, 2023 - 2035 ($ Million)
|
|
UAE Alzheimers Disease Diagnostics Market, By End User, 2023 - 2035 ($ Million)
|
|
Israel Alzheimers Disease Diagnostics Market, By Diagnostic Test, 2023 - 2035 ($ Million)
|
|
Israel Alzheimers Disease Diagnostics Market, By End User, 2023 - 2035 ($ Million)
|
|
South Africa Alzheimers Disease Diagnostics Market, By Diagnostic Test, 2023 - 2035 ($ Million)
|
|
South Africa Alzheimers Disease Diagnostics Market, By End User, 2023 - 2035 ($ Million)
|
|
Rest of Middle East & Africa Alzheimers Disease Diagnostics Market, By Diagnostic Test, 2023 - 2035 ($ Million)
|
|
Rest of Middle East & Africa Alzheimers Disease Diagnostics Market, By End User, 2023 - 2035 ($ Million)
|
|
The report includes the global Alzheimers Disease Diagnostics market size and forecast data for the following segments within each of the mentioned countries and regions.
DATA PARAMETERS:
- Historic Years: 2023 to 2024
- Base Year (for Calculation): 2024
- Estimated Year: 2025
- Forecast Years: 2026 to 2035
- Market Size & Forecast Parameter(s): Value ($ Million)
|
MARKET SEGMENTS |
COUNTRIES & REGIONS COVERED |
|
Alzheimers Disease Diagnostics Market by Diagnostic Test
Alzheimers Disease Diagnostics Market by Type
Alzheimers Disease Diagnostics Market by End User
|
GLOBAL North America
Europe
Asia Pacific
South America
Middle East & Africa
|